- Home
- SCOR vs IGC Comparison
SCOR vs IGC Comparison
Compare SCOR & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- IGC
- Stock Information
- Founded
- SCOR 1999
- IGC 2005
- Country
- SCOR United States
- IGC United States
- Employees
- SCOR N/A
- IGC N/A
- Industry
- SCOR Business Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- IGC Health Care
- Exchange
- SCOR Nasdaq
- IGC Nasdaq
- Market Cap
- SCOR 37.1M
- IGC 39.8M
- IPO Year
- SCOR 2007
- IGC N/A
- Fundamental
- Price
- SCOR $7.36
- IGC $0.40
- Analyst Decision
- SCOR
- IGC Strong Buy
- Analyst Count
- SCOR 0
- IGC 2
- Target Price
- SCOR N/A
- IGC $4.00
- AVG Volume (30 Days)
- SCOR 12.2K
- IGC 905.0K
- Earning Date
- SCOR 11-04-2025
- IGC 11-14-2025
- Dividend Yield
- SCOR N/A
- IGC N/A
- EPS Growth
- SCOR N/A
- IGC N/A
- EPS
- SCOR N/A
- IGC N/A
- Revenue
- SCOR $358,513,000.00
- IGC $1,327,000.00
- Revenue This Year
- SCOR $3.45
- IGC $3.54
- Revenue Next Year
- SCOR $2.59
- IGC $15.12
- P/E Ratio
- SCOR N/A
- IGC N/A
- Revenue Growth
- SCOR N/A
- IGC 24.95
- 52 Week Low
- SCOR $4.39
- IGC $0.25
- 52 Week High
- SCOR $10.18
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- SCOR 48.33
- IGC 46.89
- Support Level
- SCOR $7.37
- IGC $0.38
- Resistance Level
- SCOR $7.85
- IGC $0.43
- Average True Range (ATR)
- SCOR 0.48
- IGC 0.02
- MACD
- SCOR -0.07
- IGC -0.00
- Stochastic Oscillator
- SCOR 19.66
- IGC 47.05
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.